127 related articles for article (PubMed ID: 26656811)
1. Factors to Govern Soluble and Insoluble Aggregate-formation in Monoclonal Antibodies.
Fukuda J; Iwura T; Yanagihara S; Kano K
Anal Sci; 2015; 31(12):1233-40. PubMed ID: 26656811
[TBL] [Abstract][Full Text] [Related]
2. Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.
Brummitt RK; Nesta DP; Chang L; Kroetsch AM; Roberts CJ
J Pharm Sci; 2011 Jun; 100(6):2104-19. PubMed ID: 21213307
[TBL] [Abstract][Full Text] [Related]
3. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
[TBL] [Abstract][Full Text] [Related]
4. High throughput formulation screening for global aggregation behaviors of three monoclonal antibodies.
Li Y; Mach H; Blue JT
J Pharm Sci; 2011 Jun; 100(6):2120-35. PubMed ID: 21491438
[TBL] [Abstract][Full Text] [Related]
5. High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration.
Zidar M; Šušterič A; Ravnik M; Kuzman D
Pharm Res; 2017 Sep; 34(9):1831-1839. PubMed ID: 28593474
[TBL] [Abstract][Full Text] [Related]
6. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.
Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM
Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of Monoclonal Antibody Aggregation from Dilute toward Concentrated Conditions.
Nicoud L; Jagielski J; Pfister D; Lazzari S; Massant J; Lattuada M; Morbidelli M
J Phys Chem B; 2016 Apr; 120(13):3267-80. PubMed ID: 27007829
[TBL] [Abstract][Full Text] [Related]
8. Effects of Protein Conformation, Apparent Solubility, and Protein-Protein Interactions on the Rates and Mechanisms of Aggregation for an IgG1Monoclonal Antibody.
Kalonia C; Toprani V; Toth R; Wahome N; Gabel I; Middaugh CR; Volkin DB
J Phys Chem B; 2016 Jul; 120(29):7062-75. PubMed ID: 27380437
[TBL] [Abstract][Full Text] [Related]
9. Structure-based engineering of a monoclonal antibody for improved solubility.
Wu SJ; Luo J; O'Neil KT; Kang J; Lacy ER; Canziani G; Baker A; Huang M; Tang QM; Raju TS; Jacobs SA; Teplyakov A; Gilliland GL; Feng Y
Protein Eng Des Sel; 2010 Aug; 23(8):643-51. PubMed ID: 20543007
[TBL] [Abstract][Full Text] [Related]
10. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species.
Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R
AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951
[TBL] [Abstract][Full Text] [Related]
11. Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies.
Thakkar SV; Sahni N; Joshi SB; Kerwin BA; He F; Volkin DB; Middaugh CR
Protein Sci; 2013 Oct; 22(10):1295-305. PubMed ID: 23893936
[TBL] [Abstract][Full Text] [Related]
12. Equilibrium studies of protein aggregates and homogeneous nucleation in protein formulation.
Kiese S; Pappenberger A; Friess W; Mahler HC
J Pharm Sci; 2010 Feb; 99(2):632-44. PubMed ID: 19548315
[TBL] [Abstract][Full Text] [Related]
13. Effects of salts from the Hofmeister series on the conformational stability, aggregation propensity, and local flexibility of an IgG1 monoclonal antibody.
Majumdar R; Manikwar P; Hickey JM; Samra HS; Sathish HA; Bishop SM; Middaugh CR; Volkin DB; Weis DD
Biochemistry; 2013 May; 52(19):3376-89. PubMed ID: 23594236
[TBL] [Abstract][Full Text] [Related]
14. Relation of Colloidal and Conformational Stabilities to Aggregate Formation in a Monoclonal Antibody.
Oyama H; Koga H; Tadokoro T; Maenaka K; Shiota A; Yokoyama M; Noda M; Torisu T; Uchiyama S
J Pharm Sci; 2020 Jan; 109(1):308-315. PubMed ID: 31669120
[TBL] [Abstract][Full Text] [Related]
15. Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions.
Yageta S; Lauer TM; Trout BL; Honda S
Mol Pharm; 2015 May; 12(5):1443-55. PubMed ID: 25871775
[TBL] [Abstract][Full Text] [Related]
16. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
[TBL] [Abstract][Full Text] [Related]
17. Effects of arginine on photostability and thermal stability of IgG1 monoclonal antibodies.
Maity H; O'Dell C; Srivastava A; Goldstein J
Curr Pharm Biotechnol; 2009 Dec; 10(8):761-6. PubMed ID: 19939215
[TBL] [Abstract][Full Text] [Related]
18. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.
Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA
Int J Pharm; 2015 Jul; 490(1-2):341-50. PubMed ID: 25835267
[TBL] [Abstract][Full Text] [Related]
19. Formulation development of therapeutic monoclonal antibodies using high-throughput fluorescence and static light scattering techniques: role of conformational and colloidal stability.
Goldberg DS; Bishop SM; Shah AU; Sathish HA
J Pharm Sci; 2011 Apr; 100(4):1306-15. PubMed ID: 20960568
[TBL] [Abstract][Full Text] [Related]
20. Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration.
Kim N; Remmele RL; Liu D; Razinkov VI; Fernandez EJ; Roberts CJ
Biophys Chem; 2013 Feb; 172():26-36. PubMed ID: 23334430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
